False information on PrEP in direct-to-consumer advertising
Lancet HIV
.
2020 Jul;7(7):e455-e456.
doi: 10.1016/S2352-3018(20)30034-5.
Epub 2020 Feb 4.
Authors
Amy S Nunn
1
,
William C Goedel
2
,
Courtney E Gomillia
3
,
Cassandra Sutten Coats
4
,
Rupa R Patel
5
,
Matthew J Murphy
6
,
Christina T Chu
6
,
Philip A Chan
6
,
Leandro A Mena
3
Affiliations
1
Department of Behavioral and Social Sciences, Brown University, Providence, RI 02912, USA. Electronic address:
[email protected]
.
2
Department of Epidemiology, School of Public Health, Brown University, Providence, RI 02912, USA.
3
Department of Population Health Science, University of Mississippi Medical Center, Jackson, MS, USA.
4
Department of Behavioral and Social Sciences, Brown University, Providence, RI 02912, USA.
5
John T Milliken Department of Internal Medicine, School of Medicine, Washington University in St Louis, Saint Louis, MO, USA.
6
Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
PMID:
32032537
DOI:
10.1016/S2352-3018(20)30034-5
No abstract available
Publication types
Research Support, N.I.H., Extramural
Comment
MeSH terms
Advertising
Direct-to-Consumer Advertising*
Drug Industry
Drug Prescriptions
HIV Infections*
Humans
Grants and funding
R25 MH083620/MH/NIMH NIH HHS/United States
R34 MH109371/MH/NIMH NIH HHS/United States